Product Information
WYMZYA FE 0.4-0.035 MG CHEW TB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.5316 per EA under NDC 68180087373. Its NADAC has been published 198 times since Dec 21, 2022.
FDA first approved this application on Mar 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180087373
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091332FDA Approved
3/23/2016
TE Code
AB
On Market Since
11/30/2020
Price Statistics
The NADAC for WYMZYA FE 0.4-0.035 MG CHEW TB has been published 198 times since Dec 21, 2022, and over the history we have for it it has risen 60.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5316 per EA |
|---|---|
| All-time high | $0.5505 (Oct 15, 2025) |
| All-time low | $0.2266 (May 22, 2024) |
| 52-week high | $0.5505 |
| 52-week low | $0.4892 |
| Median price | $0.4440 |
| Average price | $0.4302 |
| Largest weekly change | +57.6% (Jul 17, 2024) |
| Weeks tracked | 198 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the NORETHINDRONE AND ETHINYL ESTRADIOL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NORETHINDRONE AND ETHINYL ESTRADIOL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of WYMZYA FE 0.4-0.035 MG CHEW TB?
The current National Average Drug Acquisition Cost (NADAC) for WYMZYA FE 0.4-0.035 MG CHEW TB, manufactured by Lupin Pharmaceuticals Inc., is $0.5316 per EA (NDC 68180087373), effective Sep 30, 2026.
How has the price of WYMZYA FE 0.4-0.035 MG CHEW TB changed over time?
Over the history we have for it, the NADAC for WYMZYA FE 0.4-0.035 MG CHEW TB has risen 60.9%. It has been tracked across 198 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for WYMZYA FE 0.4-0.035 MG CHEW TB?
Since Dec 21, 2022, the NADAC for WYMZYA FE 0.4-0.035 MG CHEW TB has ranged from a low of $0.2266 (May 22, 2024) to a high of $0.5505 (Oct 15, 2025), with a median of $0.4440 per EA.
Are there cheaper alternatives to WYMZYA FE 0.4-0.035 MG CHEW TB?
No other NADAC-published product currently shares the active ingredient and strength of WYMZYA FE 0.4-0.035 MG CHEW TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures WYMZYA FE 0.4-0.035 MG CHEW TB?
WYMZYA FE 0.4-0.035 MG CHEW TB (NDC 68180087373) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.